Daratumumab Induced Acute Reversible Psychological Symptom in a Multiple Myeloma Patient: An Unreported Tale of Daratumumab

Multiple Myeloma (MM) is second most common currently incurable haematological cancer. Significant improvement has been made in management of MM and integration of daratumumaban anti-CD38 humanised monoclonal antibody with other anti-MM treatments has improved the MM survival considerably...